TLR5 as an Anti-Inflammatory Target and Modifier Gene in Cystic Fibrosis-Reference-Cited by-同舟云学术

TLR5 as an Anti-Inflammatory Target and Modifier Gene in Cystic Fibrosis

Published:2010-11-10 Issue:12 Volume:185 Page:7731-7738
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Blohmke Christoph J.,Park Julie,Hirschfeld Aaron F.,Victor Rachel E.,Schneiderman Julia,Stefanowicz Dorota,Chilvers Mark A.,Durie Peter R.,Corey Mary,Zielenski Julian,Dorfman Ruslan,Sandford Andrew J.,Daley Denise,Turvey Stuart E.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference68 articles.

1. Cystic fibrosis

2. Inflammation and Anti-Inflammatory Therapies for Cystic Fibrosis

3. ALTERNATE-DAY PREDNISONE REDUCES MORBIDITY AND IMPROVES PULMONARY FUNCTION IN CYSTIC FIBROSIS

4. Risk of Persistent Growth Impairment after Alternate-Day Prednisone Treatment in Children with Cystic Fibrosis

5. A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Flagellum-deficient Pseudomonas aeruginosa is more virulent than non-motile but flagellated mutants in a cystic fibrosis mouse model;Microbiology Spectrum;2024-09-09

2. Lack of Association of TLR1 and TLR5 Coding Variants with Mortality in a Large Multicenter Cohort of Melioidosis Patients;The American Journal of Tropical Medicine and Hygiene;2024-05-01

3. LIPUS can promote osteogenesis of hPDLCs and inhibit the periodontal inflammatory response via TLR5;Oral Diseases;2023-11-20

4. Lung Inflammatory Genes in Cystic Fibrosis and Their Relevance to Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapies;Genes;2023-10-20

5. Endogenous Reverse Transcriptase Inhibition Attenuates TLR5-Mediated Inflammation;mBio;2023-02-28